A dual MET/AXL small‐molecule inhibitor exerts efficacy against gastric carcinoma through killing cancer cells as well as modulating tumor microenvironment

The receptor tyrosine kinases MET and AXL have been implicated in tumorigenesis and aggressiveness of multiple malignancies. We performed this study to evaluate the antitumor impact of LY2801653, a dual MET and AXL inhibitor on gastric cancer and to elucidate the underlying mechanisms. In the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Chenjing, Shi, Huashan, Wu, Min, Wei, Xiawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489669/
https://www.ncbi.nlm.nih.gov/pubmed/34766112
http://dx.doi.org/10.1002/mco2.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489669/
https://www.ncbi.nlm.nih.gov/pubmed/34766112
http://dx.doi.org/10.1002/mco2.11

Ejemplares similares